South Africa vs East Timor: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
South Africa
1.0%
in 2024
East Timor
1.0%
in 2024
South Africa rank
34th
East Timor rank
34th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- South Africa
- East Timor
How they compare
South Africa currently reports 1.0% against 1.0% in East Timor, a difference of 0.0%.
Across all 10 years both countries report, East Timor has been ahead every year.
South Africa ranks 34th and East Timor ranks 34th of 247 countries.
East Timor has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | South Africa | East Timor | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.3% | 2.5% | 1.1% | East Timor |
| 2020s | 1.1% | 1.3% | 0.2% | East Timor |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, South Africa or East Timor?
- South Africa, at 1.0% against 1.0% in East Timor as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between South Africa and East Timor?
- 0.0%, with South Africa ahead.
- How many years of comparable data are there for South Africa and East Timor?
- 10 years are reported by both, from 2015 to 2024.
- How do South Africa and East Timor rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- South Africa ranks 34th and East Timor ranks 34th of 247 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.